Your browser doesn't support javascript.
loading
Clinical Associations with the differences in rivaroxaban dosing in patients with atrial fibrillation stratified by three renal function formulae.
Al-Maqbali, Juhaina Salim; Alawi, Abdullah M Al; Al-Adawi, Maria; Al-Falahi, Zubaida; Al-Azizi, Asia; Al Badi, Kholoud; Rawahi, Mohamed Al.
Afiliação
  • Al-Maqbali JS; MSc. Department of Pharmacy, Sultan Qaboos University Hospital, Muscat, Oman. jsmm14@gmail.com.
  • Alawi AMA; Department of Medicine, Sultan Qaboos University Hospital, Oman Medical Specialty Board, Muscat, Oman. Dr.abdullahalalawi@gmail.com.
  • Al-Adawi M; Oman Medical Specialty Board, Muscat, Oman. maria.adawi@gmail.com.
  • Al-Falahi Z; Department of Medicine, Sultan Qaboos University Hospital, Oman Medical Specialty Board, Muscat, Oman. z.alfalahi@squ.edu.om.
  • Al-Azizi A; Pharmacutical care and medical Store Department, Samail Hospital, Samail, Oman. ph.alazizi@gmail.com.
  • Al Badi K; Department of Pharmacy, Diwan of the Royal Court Polyclinic, Muscat, Oman. kholoud.albadi89@gmail.com.
  • Rawahi MA; Department of Medicine, Sultan Qaboos University Hospital, Oman Medical Specialty Board, National Heart Center, The Royal Hospital, Muscat, Oman. mrawahi@squ.edu.om.
Pharm Pract (Granada) ; 21(1): 2758, 2023.
Article em En | MEDLINE | ID: mdl-37090449

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article